How Can We Help?
You are here:
< Back
Pharmaceutical drug
Fuzuloparib (trade name AiRuiYi) is a pharmaceutical drug for the treatment of ovarian cancer.[1] It is approved for use in China.[2] It is an inhibitor of the poly (ADP-ribose) polymerase (PARP) enzyme.[3]
It is also being studied for its potential use for the treatment of pancreatic, breast, prostate, and lung cancer.[2]
References
- ^ Li N, Liu Q, Tian Y, Wu L (November 2022). "Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective". Journal of Gynecologic Oncology. 33 (6): e86. doi:10.3802/jgo.2022.33.e86. PMC 9634097. PMID 36335989.
- ^ a b Lee A (July 2021). "Fuzuloparib: First Approval". Drugs. 81 (10): 1221–1226. doi:10.1007/s40265-021-01541-x. PMC 8380563. PMID 34118019.
- ^ "Fuzuloparib - Jiangsu HengRui Medicine". AdisInsight. Springer Nature Switzerland AG.
Categories
-
Annuals36
-
Bulbs, Corms & Tubers41
-
Ferns27
-
Fruits3
-
Garden Plants23
-
Grasses26
-
Herb17
-
Insects1
-
Mammals1
-
Midwest Native Plants0
-
Northeast Native Plants112
-
Perennials123
-
Rose1
-
Shrubs47
-
Trees112
-
Tropical Plants53
-
Upland Birds5
-
Vines18
-
Viola Tricolor1
-
Water Gardening & Plants9
-
Waterfowl0
-
Wetland Birds0
-
Wetland Plants4
-
Wildbirds172
-
Wildflowers1
-
Woodland Plants29
Table of Contents
Recent Comments